Sylvia Fedoruk Canadian Centre for Nuclear Innovation at the University of Saskatchewan
Placing Saskatchewan and Canada among global leaders in nuclear research, development and training through:
Investing in cutting-edge programs and projects
Managing research facilities, and
Partnering with academia and industry on science and technology
Fedoruk Centre Response to the COVID-19 Virus Outbreak (2020 March 27)
We are continuing to live through an unusual situation of uncertainty arising from the new COVID-19 virus and the worldwide response to its spread. The situation is evolving daily.
Our top priority is the safety of our staff, users, and the public, as well as our capability to supply the nuclear imaging agent FDG to regional hospitals, essential for PET-CT scanning of patients to diagnose and treat cancer.
As of today, the Saskatchewan Centre for Cyclotron Sciences (SCCS) is producing FDG for the Royal University Hospital in Saskatoon, and maintaining a state of readiness to produce FDG for delivery to regional hospitals. Access of researchers to the SCCS is now limited to exceptional circumstances and requires prior approval by SCCS Facility Manager, Dale Schick-Martin.
The Fedoruk Centre welcomes users to advance their programs of research and development through access to our state-of-the-art facilities and expertise.